Cystic fibrosis cell models for high-throughput analysis and drug screening
- 26 July 2024
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (4) , 716-724
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP200668)
- Cystic Fibrosis Foundation (BAO19XX0)
- Cystic Fibrosis Foundation (BAO19XX1)
This publication has 39 references indexed in Scilit:
- A review of cystic fibrosis: Basic and clinical aspectsAnimal Models and Experimental Medicine, 2021
- Animal and Cell Culture Models for Cystic FibrosisThe American Journal of Pathology, 2021
- Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registriesJournal of Cystic Fibrosis, 2020
- Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cellsJournal of Cystic Fibrosis, 2019
- CFTR modulator theratyping: Current status, gaps and future directionsJournal of Cystic Fibrosis, 2019
- Animal and model systems for studying cystic fibrosisJournal of Cystic Fibrosis, 2018
- Role of CFTR in epithelial physiologyCellular and Molecular Life Sciences, 2016
- Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or functionJournal of Cystic Fibrosis, 2014
- The Stop Mutation R553X in the CFTR Gene Results in Exon SkippingGenomics, 1994
- Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosisCell, 1990